1.Chromosomal aberrations and hematological indices in irradiation exposure peoples
Journal of Vietnamese Medicine 1999;232(1):26-30
We analyzed on chromosome of peripheral blood cell in comparison to hematological indices from 63 peoples between 1 and 31 years of irradiation exposure. The result showed that the aberrating rate was high in studied groups than control group significantly, especially, the rate of dysenteric choromosome. The hematological alteration is not clear yet.
Chromosome Aberrations
;
Whole-Body Irradiation
2.The Effect of Whole Body Irradiation for the Treatment of Myasthenia Gravis.
Young Bae LEE ; Kyoung Hoon HONG ; Myung Kwon KIM ; Hee Tae KIM ; Seung Hyun KIM ; Ju Han KIM ; Myung Ho KIM
Journal of the Korean Neurological Association 1996;14(1):197-205
This study is designed to evaluate the effect of low-dose whole body irradiation (WBI) for treatment of myasthenia gravis(MG) and changes of immunological parameters. According to MG protocol of low dose WBI, eleven patients were selected and followed up for at least one year. Clinical status and immunological parameters were assessed at the time of pretreatment (baseline) and 1, 2, 3, 6, 12 months after initial dose irradiation. The improvement began five weeks after WBI and lasted for 12-month follow-up in 7 patients (good responders) Clinical improvement and immunological changes were more pronounced in good responders. So, it is suggested that low dose WBI may have the role in the treatment of the MG as an another therapeutic modality.
Follow-Up Studies
;
Humans
;
Myasthenia Gravis*
;
Whole-Body Irradiation*
3.Development of Total Body Irradiation Program.
Byung Ock CHOI ; Ji Sun JANG ; Young Nam KANG ; Ihl Bohng CHOI ; Sung Kyun SHIN
Korean Journal of Medical Physics 2005;16(3):130-137
In total body irradiation (TBI) for leukemia, we have a two methode. One is a AP (anterior-posterior) method and the other is a Lateral methode. Our hospital used lateral methode. TBI must consider about body contour, because of homogeneous dose distribution. For compensation about irregular body contour, we use compensator. For TBI treatment, we must be considered, accurate manufacture of compensator and accurate calculation of dose. We developed the automatic program for TBI. This program accomplished for compensator design and dose calculation for irregular body. This program was developed for uses to use in a windows environment using the IDL language. In this program, it use energy data for each energy: TMR, output factor, inverse square law, spoiler, field size factor. This program reduces the error to happen due to the manual. As a development of program, we could decrease the time of treatment plan and care the patient accurately.
Compensation and Redress
;
Humans
;
Jurisprudence
;
Leukemia
;
Whole-Body Irradiation*
4.Total Body Irradiation Technique: Basic Data Measurements and In Vivo Dosimetry.
Dong Rak CHOI ; Ihl Bohng CHOI ; Ki Mun KANG ; Kyung Sub SHINN ; Choon Choo KIM
Journal of the Korean Society for Therapeutic Radiology 1994;12(2):219-224
This paper describes the basic date measurements for total body irradiation with 6 Mv photon beam including compensators designs. The technique uses bilateral opposing field with tissue compensators for the head, neck, lungs, and legs from the hip to toes. In vivo dosimetry was carried out for determining absorbed dose at various regions in 7 patients using diode detectors (MULTIDOSE, Model 9310, MULTIDATA Co., USA). As a results, the dose uniformity of+/-3.5%(generally, within+/-10%) can be achieved with our total body irradiation technique.
Head
;
Hip
;
Humans
;
Leg
;
Lung
;
Neck
;
Toes
;
Whole-Body Irradiation*
5.Acute Response to Co-60 Total Body Irradiation (TBI) With 600 cgy at 3 Different Does Rates in the Mice.
Cheol Hoon KANG ; Sung Kyu KUM ; Sei One SHIN ; Myung Se KIM
Journal of the Korean Society for Therapeutic Radiology 1990;8(2):151-154
The acute effects of variable dos rates to total body irradiation (TBI) were investigated with 600 cgy of single exposure in the mice as a preclinical model. Total 80 mice (ICR) were used. Twenty of which served as controls, receiving no irradiation. All irradiated mice showed a universal decline in their weight and white blood cell count. The degree of weight loss and leukopenia were similar at 3 different dos rate but slightly prominent with 15 cgy/minute group. The degree of recovery among the groups showed no dose rate dependence. Our results suggest that TBI with 15 cgy/minute may be applicable for clinical therapy with careful evaluation of patient's condition.
Animals
;
Leukocyte Count
;
Leukopenia
;
Mice*
;
Weight Loss
;
Whole-Body Irradiation*
6.In vivo and in vitro Confirmation of Dose Homogeneity in Total Body Irradiation with Thermoluminescent Dosimeter.
Eui Kyu CHIE ; Suk Won PARK ; Wee Saing KANG ; Il Han KIM
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1999;17(4):321-338
PURPOSE: Total body irradiation (TBI) or whole body irradiation is used to acquire immune suppression, to treat malignant lymphoma and leukemia, and as an conditioning regimen for bone marrow transplantation. For these purposes, many methods were developed to obtain homogenous dose distribution. The objective of this study was to analyze and confirm the accuracy and the homogeneity of the treatment setup, the parallel opposed lateral technique, currently used in Seoul National University Hospital. MATERIALS AND METHODS: Surface dose data, measured with a thermoluminescent dosimeter, of 8 patients among 10 patients, who were given total body irradiation with the parallel opposed lateral technique between September 1996 to August 1998, at Seoul National University Hospital were analyzed. Surface doses were measured at the head, neck, axilla, thigh, and ankle level. Surface and midline doses were measured with similar set-up and technique in the Humanoid phantom. RESULTS: Measured surface doses relative to prescribed dose for the head, neck, axilla, thigh, and ankle level were 91.3+/-7.8, 98.3+/-7.5, 95.1+/-6.3, 98.3+/-5.5, and 95.3+/-6.3%, respectively. The midline doses of the head, neck, axilla, thigh, and ankle level estimated from the surface-to-midline ratios in the Humanoid phantom were 103.4+/-9.0, 107.8+/-10.5, 91.1+/-6.1, 93.8+/-4.5, and 104.5+/-9.3%, respectively. Measured surface doses and estimated midline doses ranged from -8.9% to + 7.8%. Midline doses at the neck and the axilla level deviated more than 5% from the prescribed doses. The difference of the estimated midline doses at the neck and the axilla level and the actual doses were attributed to the thickness differences between the Humanoid phantom and the patients. CONCLUSION: Distribution of the midline doses as well as the surface doses were measured to be within -8.7 - +7.8% range. Actual dose distribution in the patient is expected to be better than the measured dose range mainly attributed to thickness difference between the patient and the Humanoid phantom.
Ankle
;
Axilla
;
Bone Marrow Transplantation
;
Head
;
Humans
;
Leukemia
;
Lymphoma
;
Neck
;
Seoul
;
Thigh
;
Whole-Body Irradiation*
7.Dosimetry and Medical Internal Radiation Dose of Re-188-DTPA for Endovascular Balloon Brachytherapy Against Restenosis after Coronary Angioplasty.
Myung Chul LEE ; June Key CHUNG ; Dong Soo LEE ; Jae Min JEONG ; Jin LEE ; Seung Ae SHIN
Korean Journal of Nuclear Medicine 1999;33(2):163-171
PURPOSE: Liquid beta emitter filled in angioplasty balloon could be used to perform endovascular balloon brachytherapy to prevent coronary artery restenosis. We investigated the dosimetry for Re-188-DTPA liquid-filled balloon and medical internal radiation dosimetry in case of balloon leakage. MATERIALS AND METHODS: We estimated radiation dose from an angioplasty balloon (20 mm lengfh, 3 mm diameter cylinder) to the adjacent vessel wall using Monte Carlo EGS4 code. We obtained time-activity curves of kidneys in normal dog and calculated Tmax, T1/2. Using MIRDOSE3 program, we estimated absorbed doses to the major organs (kidneys, bladder) and the whole body when we assumed that balloon leaked all the isotope contained. RESULTS: The radiation dose was 17.5 Gy at the balloon surface when we applied 3,700 MBq/ml of Re-188 for 100 seconds. Fifty percent of the energy deposited within 1 mm from the balloon surface. The estimated internal dose to the whole body was 0.005 mGy/MBq and 18.5 mGy for the spillage of 3,700 MBq of Re-188. CONCLUSION: We suggest that Re-188-DTPA can be used for endovascular balloon brachytherapy to inhibit coronary artery restenosis after angioplasty with tolerable whole body radiation dose in case of balloon rupture.
Angioplasty*
;
Animals
;
Brachytherapy*
;
Coronary Vessels
;
Dogs
;
Kidney
;
Radiometry
;
Rupture
;
Whole-Body Irradiation
8.A Case of Juvenile Dermatomyositis Treated with Intravenous Gammaglobulin.
Hyun Jeong PARK ; Young Min PARK ; Jong Yuk YI ; Tae Yoon KIM ; Chung Won KIM
Korean Journal of Dermatology 1996;34(4):656-659
Dermatomyositis is an inflammatory muscular disease of presumed autoimmune origin. Many possible interventions are available to treat patients with these conditions including corticosteroids, immunosuppressive drugs, plasnapheresis, and total body irradiation. But these therapies are not always effective, and they may be associated with certain serious side effects. Recently polyvalent. intravenous gammaglohulin(IVGG) has been tried with success in inflammatory myopathies after failure of traditional treatment We report a 8-year-old female patient with juvenile dermatomyositis who improved dramatically after alternative IVGG treatment due to side effects of steroid.
Adrenal Cortex Hormones
;
Child
;
Dermatomyositis*
;
Female
;
Humans
;
Muscular Diseases
;
Myositis
;
Whole-Body Irradiation
9.Whole Body Irradiation on 4 Cases of Myasthenia Gravis: Pilot Study.
Sung Soo KANG ; Hyeong Cheol KIM ; Dae Il CHANG ; Ju Han KIM ; Myuong Ho KIM ; Ha Chung CHUN
Journal of the Korean Neurological Association 1992;10(1):28-32
Myasthenia Gravis can be considered a lymphocyte dyscrasia. We report four cases of myasLhenia gravis, who were treated with whole body irradiation. Total of 180 rad was delivered in 9 fractions for 3 weeks with every other day treabmenL Three out of four cases showed remarkable symptomatic improvement on follow-up during 3 months.
Follow-Up Studies
;
Lymphocytes
;
Myasthenia Gravis*
;
Pilot Projects*
;
Whole-Body Irradiation*
10.Factors Affecting Normal Pubertal Development after bone Marrow Transplantation in Girls.
Hyun Hee JO ; Mee Ran KIM ; Dong Jin KWON ; Jang Heub KIM ; In Kyung SUNG ; Jin Hong KIM
Korean Journal of Obstetrics and Gynecology 2004;47(2):320-325
OBJECTIVE: To evaulate the factors affecting pubertal development after bone marrow transplantation (BMT) in girls. METHODS: We collected data from girls older than 14 on 2003, who had received bone marrow transplantation with or without total body irradiation. We checked their menstrual pattern, onset of menarche, growth rate before and after the transplantation using chart review. RESULTS: 41.6% of girls who took menarche before BMT mensurate regularly and 100% of girls who didn't take menarche before BMT suffered by amenorrhea. Time period from BMT to menarche is 0.6 years in the regular-menstruating group, and 2.14 years in the secndary amenorrhea group. 37.5% of girls who didn't take total body irradiation menstrate regularly, but only 15.3% of girls who took total body irradiation menstrate regularly. 100% of girls who showed decreasing growth rate after BMT diagnosed primary or secondary amenorrhea and 75% of girls showed increasing growth rate after BMT menstrated regularly. CONCLUSION: Ovary is more vulnerable before menarche. Time of menarche, time period between menarche and BMT, and radiation are the most important factors affecting ovarian function after bone marrow transplantation.
Amenorrhea
;
Bone Marrow Transplantation*
;
Bone Marrow*
;
Female*
;
Humans
;
Menarche
;
Ovary
;
Whole-Body Irradiation